Gateway Wealth Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
4,832
-2,777
-36% -$1.03M 0.12% 193
2026
Q1
$2.06M Buy
7,609
+5,383
+242% +$1.6M 0.08% 248
2025
Q4
$735K Sell
2,226
-377
-14% -$128K 0.08% 227
2025
Q3
$899K Buy
2,603
+561
+27% +$170K 0.12% 172
2025
Q2
$637K Buy
2,042
+789
+63% +$302K 0.12% 176
2025
Q1
$656K Buy
1,253
+95
+8% +$48.6K 0.15% 150
2024
Q4
$586K Buy
1,158
+12
+1% +$6.82K 0.15% 146
2024
Q3
$670K Sell
1,146
-65
-5% -$36.8K 0.18% 118
2024
Q2
$617K Buy
1,211
+313
+35% +$153K 0.19% 129
2024
Q1
$444K Buy
898
+143
+19% +$72.7K 0.16% 128
2023
Q4
$397K Sell
755
-101
-12% -$53.9K 0.16% 125
2023
Q3
$431K Buy
856
+100
+13% +$49.2K 0.08% 145
2023
Q2
$363K Sell
756
-22,551
-97% -$11M 0.06% 158
2023
Q1
$11M Sell
23,307
-372
-2% -$180K 1.69% 13
2022
Q4
$12.6M Buy
+23,679
New +$12.5M 2.16% 12

Other funds holding UNH

Gateway Wealth Partners's UNH Position: Q2 2026 in Review

Gateway Wealth Partners reduced its UnitedHealth (UNH) stake by 36% in Q2 2026, selling an estimated $1.03M and leaving 4,832 shares worth $2.01M. The position accounts for 0.12% of the portfolio, ranked #193.

Gateway Wealth Partners first reported a position in UNH in Q4 2022 and has held it in 15 quarters since. The position peaked at $12.6M in Q4 2022. 1,773 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Gateway Wealth Partners held 4,832 shares of UnitedHealth worth $2.01M as of Q2 2026.
  • Gateway Wealth Partners sold 2,777 UnitedHealth shares in Q2 2026, an estimated $1.03M.
  • UnitedHealth made up 0.12% of Gateway Wealth Partners's portfolio in Q2 2026, its #193 holding.
  • Gateway Wealth Partners first reported a position in UnitedHealth in Q4 2022 and has held it in 15 quarters since.
  • Gateway Wealth Partners's UnitedHealth position peaked at $12.6M in Q4 2022.
  • 1,773 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.